News, Articles & Resources
Cancer Research and Cancer Support Articles
Breast cancer starts when normal, healthy cells in the tissues of the breast become changed or altered and begin to grow out of control.
Learn about the importance of sleep hygiene and healthy sleep practices in promoting emotional wellbeing and coping skills in this edition of the FCS Behavioral Health Newsletter.
Richard McDonough, MD has been appointed as FCS Director of Patient Advocacy
Bradley Monk, MD will join Florida Cancer Specialists & Research Institute as Medical Director of Late-Phase Research effective in January 2024.
New technologies are helping to target tumors more precisely, reduce side effects and enhance patient comfort.
Research conducted by FCS confirmed the effectiveness of a new medication in protecting bone marrow of patients who receive chemotherapy for small cell lung cancer.
Hematologists and medical oncologists Bahaa Amer, MD and Savan Shah, MD join FCS in Sarasota and Clearwater
PQI in Action for medically integrated teams on blood cancers and disorders co-authored by FCS clinicians
FCS Top News Updates
October 23, 2026
FCS Drug Development Research Featured at ESMO Congress 2026
October 20, 2026
FCS Leadership Review of Step Therapy Policies Details Troubling Impacts to Cancer Patients
October 19, 2026
FCS Welcomes Kelly Elleson, MD, FACS, Breast and Melanoma Surgical Oncologist
October 15, 2026
FCS Clinical Summit Advances Strategic Priorities, Research Innovation & Excellence in Patient Care
Breast Cancer – Summary, Symptoms, TreatmentsBreast cancer starts when normal, healthy cells in the tissues of the breast become changed or altered and begin to grow out of control.
Practicing Healthy Sleep Practices and Sleep Hygiene to Promote WellbeingLearn about the importance of sleep hygiene and healthy sleep practices in promoting emotional wellbeing and coping skills in this edition of the FCS Behavioral Health Newsletter.
Richard McDonough, MD has been appointed as FCS Director of Patient AdvocacyRichard McDonough, MD has been appointed as FCS Director of Patient Advocacy
Bradley Monk, MD will join FCS as Medical Director of Late-Phase Research effective in January 2024Bradley Monk, MD will join Florida Cancer Specialists & Research Institute as Medical Director of Late-Phase Research effective in January 2024.
New Technologies Enhance Safety and Comfort for Patients Receiving RadiationNew technologies are helping to target tumors more precisely, reduce side effects and enhance patient comfort.
New Treatment Minimizes Side Effects of Chemotherapy for Lung Cancer PatientsResearch conducted by FCS confirmed the effectiveness of a new medication in protecting bone marrow of patients who receive chemotherapy for small cell lung cancer.
Bahaa Amer, MD and Savan Shah, MD join FCS in Sarasota and ClearwaterHematologists and medical oncologists Bahaa Amer, MD and Savan Shah, MD join FCS in Sarasota and Clearwater
FCS Clinicians Co-author Positive Quality Intervention for Blood Cancers and DisordersPQI in Action for medically integrated teams on blood cancers and disorders co-authored by FCS clinicians